# evo ON-THE-GO ANTI-CAVITY FLUORIDE-SPEARMINT (Sodium Fluoride) by Ashtel Studios, Inc.: new human otc drug listing

**Launch Signal Score:** 15/100

| Field | Value |
|---|---|
| Product | evo ON-THE-GO ANTI-CAVITY FLUORIDE-SPEARMINT |
| Generic name | Sodium Fluoride |
| NDC | 70108-246 |
| Labeler | Ashtel Studios, Inc. |
| Product type | HUMAN OTC DRUG |
| Approval pathway | OTC MONOGRAPH DRUG |
| Application number | M021 |
| Dosage form | MOUTHWASH |
| Route | ORAL |
| Active ingredients | SODIUM FLUORIDE .05 g/100mL |
| Marketing start | 2026-10-20 |
| Package configurations | 1 |

## Why this score


Source: U.S. FDA National Drug Code (NDC) Directory via openFDA (https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=70108-246). Last refreshed: 2026-11-05T20:38:44.874Z.
Listing data comes from the FDA NDC directory via openFDA; a listing is not an FDA approval or endorsement and may be updated or withdrawn. Informational only; not medical advice.